DDi

DDi is a private, Zurich-based provider of digital automation and intelligence platforms for highly regulated life sciences sectors. The company leverages a modular, AI-powered suite of products to address critical workflows in regulatory affairs, clinical trial supply, quality management, and document control. It targets both large enterprises and SMBs, promising significant efficiency gains and a strong ROI through its fit-for-purpose solutions. DDi appears to be in a revenue-generating stage, supported by a client base of enterprise and mid-market companies.

Modular suite of AI-powered automation platforms for regulatory affairs (REGai), clinical trial supply, quality management, and enterprise content management, featuring a dedicated Agentic AI platform for complex workflow orchestration.

DDi competes in the regulatory technology (RegTech) and life sciences enterprise software market against large players like Veeva Systems and IQVIA, as well as numerous niche specialists. Its differentiation lies in a modular architecture, deep domain-specific automation, and an early focus on developing fit-for-purpose agentic AI for complex workflows.